Inhibiting the NF-κB pathway, a critical regulator of inflammation can suppress the production of pro-tumorigenic factors like VEGF and MMPs by neutrophils, reducing tumor growth and metastasis. This evidence concerns the gene NFKB1 and neoplasm.